Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:2237-2243

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, M.-H.
Right arrow Articles by Chen, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, M.-H.
Right arrow Articles by Chen, S.-A.
Related Collections
Right arrow Pulmonary circulation and disease
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 1999;100:2237.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Alterations of Heart Rate Variability After Radiofrequency Catheter Ablation of Focal Atrial Fibrillation Originating From Pulmonary Veins

Presented in part at the 48th Scientific Sessions of the American College of Cardiology, New Orleans, La, March 9, 1999, and published in abstract form (J Am Coll Cardiol. 1999;33:144A). Also presented in part at the 20th Scientific Sessions of the North American Society of Pacing and Electrophysiology, Toronto, Canada, May 14, 1999, and published in abstract form (Pacing Clin Electrophysiol. 1999;22:857).

Ming-Hsiung Hsieh, MD; Chuen-Wang Chiou, MD; Zu-Chi Wen, MD; Chieh-Hung Wu, MD; Ching-Tai Tai, MD; Chin-Feng Tsai, MD; Yu-An Ding, MD; Mau-Song Chang, MD; Shih-Ann Chen, MD

From the Division of Cardiology, Department of Medicine, National Yang-Ming University, School of Medicine, and Veterans General Hospital-Taipei (Z.-C.W., C.-H.W., C.-T.T., C.-F.T., Y.-A.D., M.-S.C., S.-A.C.), and Kaohsiung (C.-W.C.), Taiwan, ROC, and the Division of Cardiovascular Medicine, Taipei Medical College and Taipei Wan-Fang Hospital. Dr Hsieh is currently with the Division of Cardiovascular Medicine, Taipei Medical College and is affiliated with Taipei Wan-Fang Hospital.

Correspondence to Shih-Ann Chen, MD, Division of Cardiology, Veterans General Hospital-Taipei, 201 Sec 2, Shih-Pai Road, Taipei, Taiwan, ROC. E-mail sachen{at}vghtpe.gov.tw


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Transient sinus bradycardia and hypotension have been reported as complications during radiofrequency (RF) ablation of focal atrial fibrillation (AF) originating from pulmonary veins (PVs). This study used heart rate variability (HRV) to evaluate the effects of focal PVs ablation on autonomic function.

Methods and Results—Thirty-seven patients with paroxysmal AF were referred for ablation. The study group included 30 patients who underwent transseptal ablation of PVs, and the control group included 7 patients who underwent the transseptal procedure without ablation. The mean sinus rate and time-domain (standard deviation of RR intervals and root-mean-square of differences of adjacent RR intervals) and frequency-domain (low frequency, high frequency, and low-frequency/high-frequency ratio) analyses of HRV were obtained by use of 24-hour Holter monitoring before and 1 week, 1 month, and 6 months after ablation. All the triggering points of AF were from PVs, and they were successfully ablated. Severe bradycardia and hypotension were noted during ablation of PVs in 6 patients (group IA); 24 patients without the above complication belonged to group IB. Compared with preablation values, a significant increase in mean sinus rate and low-frequency/high-frequency ratio and a significant decrease in standard deviation of RR intervals, root-mean-square of differences of adjacent RR intervals, low frequency, and high frequency were noted in groups IA and IB patients 1 week after ablation. The changes in HR and HRV recovered spontaneously in the 2 subgroups by 1 month later. These parameters of HRV did not change in the control group after the transseptal procedure.

Conclusions—Transient autonomic dysfunction with alterations in HR and HRV occurred after ablation of focal AF originating from PVs.


Key Words: fibrillation • veins • ablation


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Autonomic dysfunction has been reported as a consequence of radiofrequency (RF) catheter ablation of various kinds of supraventricular tachycardia.1 2 3 4 5 6 Several reports have demonstrated an increase in heart rate (HR) and a decrease in HR variability (HRV) after ablation of slow atrioventricular nodal, posteroseptal, and para-hisian accessory pathways.2 3 4 5 6 These reports suggested that transient parasympathetic nervous withdrawal might be one of the mechanisms that causes these HR effects when RF energy is applied around these pathways. Recently, RF catheter ablation of pulmonary veins (PVs) has been demonstrated to cure focal atrial fibrillation (AF).7 8 9 10 However, transient sinus bradycardia, sinus arrest, and hypotension have been reported as complications during focal ablation of PVs, and thermal stimulation of vagus nerve fibers might play an important role in these complications.9 Therefore, the purpose of the present study was to evaluate the effects of focal PVs ablation on autonomic function by using HRV.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Thirty-seven patients (26 men, 11 women; mean age, 58±11 years; range, 27 to 75 years) with frequent attacks of paroxysmal AF were referred for electrophysiological study or catheter ablation. The study group included 30 patients (group I) who underwent the transseptal procedure for ablation of PVs, and a control group (group II) included 7 patients who only underwent the transseptal procedure without ablation. These patients gave informed consent. As described previously, all antiarrhythmic drugs were discontinued for at least 5 half-lives before the study.9 10 The patients who took amiodarone for management of AF were excluded.

Twenty-Four-Hour Holter Monitoring
All the patients received ambulatory 24-hour Holter monitoring before, 1 week, and 1 and 6 months after focal ablation of PVs. We did not perform Holter monitoring 1 day after ablation, because postprocedural pain, hypovolemia, and anxiety may contribute to the alterations in HR and HRV.1 Holter monitoring was performed using a 3-channel bipolar recorder and was evaluated after digitization by an Oxford Medilog Excel II analysis system. For each hour, the following data were computed and tabulated: maximal and minimal HR; total number of ventricular premature beats, including couplets and ventricular tachycardia; and total number of supraventricular premature beats. The mean sinus rate was derived from the mean RR intervals (after exclusion of abnormal beats), and the maximal sinus rate was derived from the maximal HR after exclusion of nonsinus rhythm. Inappropriate sinus tachycardia was defined as a resting mean sinus rate of >100 bpm without physiological or hemodynamic causes.

Heart Rate Variability
The analysis technique has been well established in this laboratory.11 12 In brief, HRV was analyzed from the Holter recordings using a commercially available software algorithm (Oxford Medilog Excel II). During the analysis, only normal beats were measured, and all artifacts or extrasystolic beats were eliminated. The beat classification was verified, manually overread, and corrected appropriately by an experienced cardiologist. The beats before the onset of AF (total, 30 seconds), during the AF episode, and after the termination of AF (total, 30 seconds) were also excluded. All the beats of exclusion must be <1% of totally available beats. The time-domain measures of HRV, including standard deviation of RR intervals (SDRR) and root-mean-square of differences of adjacent RR intervals (rMSSD), were obtained by using the continuous data throughout 24 hours. The frequency-domain analysis of HRV was performed by a fast Fourier transform of the RR intervals, which produced a power spectrum from the 0.01- to 1.0-Hz unit (1 cycle per second). Three frequency-domain measures of HRV, including low frequency (LF; range, 0.04 to 0.15 Hz), high frequency (HF; range, 0.15 to 0.40 Hz), and LF/HF ratio were calculated. The SDRR, rMSSD, and HF are known to reflect the activity of the parasympathetic nervous system, and LF/HF ratio is interpreted to be a marker of sympathovagal balance.11 12 13 14 15

Electrophysiological Study and Catheter Ablation
As described previously, 2 multipolar electrode catheters were placed in the anterolateral right atrium and His bundle area for recording and pacing.10 A 7F decapolar catheter was inserted into the coronary sinus. After a successful atrial transseptal puncture, 2 exchange guidewires were introduced into the left atrium through the interatrial septum, and then 2 long sheaths (8F SR0 for left superior pulmonary vein [LSPV] and 8.5F SL1 for right superior pulmonary vein [RSPV]; Daig Co) were advanced along the guidewires into the left atrium. Two 6F decapolar catheters were put into the RSPV and LSPV, guided by the pulmonary venography (Figure 1Down). Intravenous heparin was administered at a dosage of 1000 to 2000 U at 1-hour intervals, if needed, to maintain activated clotting time >250 seconds after the atrial transseptal procedure.



View larger version (116K):
[in this window]
[in a new window]
 
Figure 1. Radiograms showed double multielectrode mapping catheters in RSPV and LSPV. A, Right anterior oblique view at 30°. B, Left anterior oblique view at 60°. HRA indicates high right atrium; HIS, His-bundle recording catheter; and CS, coronary sinus catheter.

Because these patients were suspected to have spontaneous onset of AF, we first tried to find spontaneous AF at the baseline or after infusion of isoproterenol (<=4 µg/min). If spontaneous AF did not appear, a short duration of burst pacing from right atrium and coronary sinus was used to facilitate spontaneous AF onset during isoproterenol infusion. If spontaneous AF could not be initiated, high-current burst pacing from right atrium or coronary sinus was used to induce AF; after the episode of pacing-induced AF was sustained for >5 minutes, external cardioversion was attempted to convert AF to sinus rhythm and observe the spontaneous reinitiation of AF. The methods used to induce spontaneous AF were tried at least twice to ensure reproducibility. The details of these techniques have been described in our laboratory.10

The presumed ablation site was chosen on the basis of the earliest bipolar activity of the triggering ectopic beats preceding AF from PVs (Figure 2Down). The ablation catheter (4-mm tip electrode, Mansfield, Boston Scientific) was put into the PV with 1 guiding catheter in situ, and ablation was performed. A temperature control model with maximal temperature setting of 60°C was used. Each application of RF energy was delivered for 20 to 40 seconds. Application of energy was stopped immediately if the patients felt burning pain or bradycardia and/or hypotension occurred. Procedural success was defined as that AF was noninducible with the same protocols before ablation.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 2. Intracardiac tracings showed successful ablation site electrogram. Spike potential (arrow) on distal pair of ablation catheters (ABL-D) was noted in atrial premature beat triggering AF. RSPV-O through RSPV-4 indicates from ostium to distal pair of RSPVs; CSO, ostium of coronary sinus catheter; CSM, middle pair of coronary sinus catheters; and CSD, distal pair of coronary sinus catheters.

Postablation Follow-Up
All the procedures and follow-up studies were performed at this institution. Close clinical follow-up and 24-hour Holter monitoring (1 week, 1 month, and 6 months after ablation) were scheduled and performed to assess the effects of catheter ablation.

Statistical Analysis
The parametric data were presented as mean±SD. Comparisons of the parametric data among the groups obtained at different time sequences were made by 1-way ANOVA with the Bonferroni correction for comparison between means. An unpaired t test was used to compare data among groups. A value of P<0.05 was considered statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Clinical Characteristics and Ablation Results
All 37 patients had frequent attacks of clinically documented paroxysmal AF (2±2 episodes per day; duration, 7±3 min/d; range, 1 to 12 minutes) and were refractory to or intolerant of 2±1 antiarrhythmic drugs. The mean number of atrial premature beats was 412±102 beats per day. Fourteen of 37 patients had associated cardiovascular disease, including hypertensive heart disease (9 patients), ischemic heart disease (2), dilated cardiomyopathy (2), and hypertrophic cardiomyopathy (1). Twenty-one patients (57%) had no associated cardiovascular or other medical diseases.

All of the study patients had spontaneous initiation of AF, as follows: during the baseline observation (1 patient), after isoproterenol infusion (5), after a short duration of atrial pacing under isoproterenol infusion (11), or after cardioversion of pacing-induced AF (13). All of the triggering points of AF in the study group were from the PVs, including 12 in the LSPV, 8 in the RSPV, and 10 in the RSPV and LSPV. Successful ablation of the PVs was achieved in all patients. Severe bradycardia (HR <40 bpm), sinus arrest, or hypotension (systolic blood pressure <90 mm Hg) was noted during applications of RF to the PVs in 6 patients (group IA); the ablation site was 7±9 mm inside the LSPV (4 patients) or 9±13 mm inside the RSPV (2 patients). The other 24 patients without this complication during ablation belonged to group IB. The ablation site was 11±10 mm inside the LSPV (10 patients), 13±12 mm inside the RSPV (6), or both in the RSPV and LSPV (8). The mean number of RF applications was 9±5 in group IA and 7±3 in group IB patients. None of the patients had bradycardia-hypotension response during the transseptal puncture. Three patients (1 in group IA and 2 in group IB) had recurrent asymptomatic AF, which was noted during 1-month follow-up Holter monitoring. Because the duration of AF attack was short (all <1 minute) and the frequency of AF was less than before ablation, the patients did not need any antiarrhythmic drug.

Acute Changes in HRV
Comparisons with the baseline data before ablation, the mean sinus rate, and maximal sinus rate were significantly higher at 1 week after ablation of PVs in groups IA and IB (TableDown). Two patients (6.7%) presented with inappropriate sinus tachycardia (mean sinus rate increased from 83 and 79 bpm to 110 and 104 bpm, respectively). SDRR, rMSSD, LF, and HF were all significantly decreased after ablation in the 2 subgroups; LF/HF ratio was also increased significantly. Furthermore, these parameters obtained before or after ablation were similar between groups IA and IB patients. In group II patients, no significant change occurred among the parameters obtained at baseline and 1 week after the transseptal procedure.


View this table:
[in this window]
[in a new window]
 
Table 1. Acute Changes in Time-Domain and Frequency-Domain Measures of HRV

Chronic Changes in HRV
One month after ablation, the mean and maximal sinus rates of all the study patients (including the 2 patients with inappropriate sinus tachycardia) returned to the baseline level; no significant change of the mean and maximal sinus rates was noted in the data before and 1 month after ablation (Figure 3ADown). SDRR, rMSSD, LF, HF, and LF/HF were not significantly different in the data obtained at before and 1 month after ablation (Figures 3BDown through 3F). These changes showed the same trends in groups IA and IB. The HRV parameters obtained at 6 months after ablation were similar compared with those obtained at baseline and 1 month after ablation (Figures 3ADown through 3F).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 3. Changes to mean sinus rate (SR) and HRV before and 1 week (1 WK), 1 month (1 M), and 6 months (6 Ms) after ablation of PVs. Group IA indicates patients with ablation-induced bradycardia-hypotension response, and group IB indicates those without the above complication. *P<0.05 among data obtained during different time sequences.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Major Findings
The present study demonstrated that focal ablation of PVs may result in a transient increase in HR and a transient decrease of time-domain and frequency-domain HRV, which indicates autonomic dysfunction (enhanced sympathetic activity or parasympathetic nervous withdrawal); these changes recovered spontaneously 1 month later. However, these changes were not present in the patients who only underwent the transseptal procedure without ablation of PVs.

Autonomic Dysfunction After Ablation of PVs
Previous studies have reported inappropriate sinus tachycardia as a complication after ablation of supraventricular tachycardias.1 2 16 17 18 19 Some possible mechanisms have been discussed, and a change of autonomic tone is the most likely explanation in these reports. These researchers used HRV to evaluate the autonomic function and found that parasympathetic nervous withdrawal occurred after ablation of supraventricular tachycardias.1 2 3 4 5 6 16 17 18 19 In the present study, the prevalence of inappropriate sinus tachycardia was 6.7%, similar to that in previous reports regarding ablation of supraventricular tachycardias.1 2 3 17 18 We also found decreases in SDRR, rMSSD, and HF and increases in mean and maximal sinus rate and LF/HF ratio, which indicates autonomic dysfunction, just like the findings after ablation of supraventricular tachycardias. Furthermore, no significant changes in HR and HRV were noted in our control group, which indicates autonomic dysfunction after ablation of PVs was not related to the transseptal procedure.

Although autonomic dysfunction may play an important role in changes in HR and HRV after ablation of slow pathway, posteroseptal space, and PVs, the precise mechanism is not clear. An increase of sympathetic tone, a decrease of parasympathetic tone, or a combination of both factors is the possible explanations. Ardell and Randall20 have shown in the canine heart that the intrapericardial projections of the left vagus to the sinus node penetrate the epicardium in the region of the common PV complex. Furthermore, the projections of the right vagus penetrate epicardium adjacent to the origin of the right PV.21 22 23 Recently, Marron et al24 identified widely distributed specialized nerve terminals in the human heart, and numerous nonmyelinated C-fibers terminals, which are believed to be responsible for cardiac depressing baroreflexes, were identified in the roof of the left atrium and around the 4 PVs. Therefore, focal ablation of PVs could result in stimulation (induced bradycardia-hypotension response) or destruction (induced parasympathetic nervous withdrawal or denervation) of postganglionic parasympathetic fibers or specialized nerve terminals in PVs, which are destined to innervate the sinus node (Figure 4Down).25



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4. Focal ablation of PV- and posteroseptal space (PS)–induced reflex bradycardia-hypotension response and parasympathetic withdrawal. Intracardiac stimulation of parasympathetic afferent nerve fibers in PV and PS during ablation resulted in enhanced efferent parasympathetic tone to sinoatrial node (SAN) (bradycardia) and decreased efferent sympathetic activity to vessels (hypotension). Focal ablation of PV or PS also could result in destruction of parasympathetic nerve fibers and induce parasympathetic withdrawal. RA indicates right atrium; SVC, superior vena cava; and IVC, inferior vena cava.

The other possibility of changes in HR and HRV is mediated by cardiac sympathovagal (so-called cardiocardiac) reflex.26 In acute myocardial infarction, the necrotic scar alters the geometry of the beating heart, which results in an increased activity of sympathetic afferent fibers secondary to distortion of their sensory endings; this change produces an inhibition of vagal efferent activity to the heart (including the sinus node) and increases efferent sympathetic activity. Therefore, an increase in HR and a decrease in HRV after myocardial infarction are the results of an enhanced sympathetic activity and parasympathetic nervous withdrawal. Some previous reports have demonstrated that cardiac sympathetic nerves form an important afferent pathway and the receptor endings of the fibers consist of free terminals scattered diffusely in the heart.22 26 27 28 These sympathetic fibers are distributed throughout the atria, but the vagal branches have a more-limited distribution to specific sites. This explains why multiple lesions in the atria (including slow atrioventricular node, para-hisian pathway, posteroseptal space, and PVs) affect preferentially the sympathetic endings and elicit an increase in HR and a decrease in HRV (Figure 5Down). Vagal fiber endings would be less affected.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 5. Focal ablation of PV and posteroseptal space resulted in sympathovagal (so-called cardiocardiac) reflex. Intracardiac stimulation of sympathetic afferent fibers during ablation produced an increase of efferent sympathetic activity and a decrease of efferent parasympathetic tone to sinus node and resulted in an increase in sinus rate and a decrease in HRV. Other abbreviations as in Figure 4Up.

Relation Between Parasympathetic Stimulation and Autonomic Dysfunction Caused by RF Energy
Friedman et al1 have shown that ablation of slow pathway or posteroseptal area could result in profound sinus bradycardia. They suggested that RF current directly stimulated parasympathetic fibers traveling from the site of RF application to the sinus node. The finding was similar to that of our previous report regarding the effect of direct intracardiac stimulation of human afferent vagal fibers.29 Because focal ablation of supraventricular tachycardias could result in stimulation of parasympathetic nerve fibers or terminals, the presence of a bradycardia-hypotension phenomenon may be related to the distribution and density of parasympathetic nerve fibers around the ablation areas. Previous animal and human studies have demonstrated numerous parasympathetic nerve terminals in the PV area, and the incidence of ablation-induced bradycardia-hypotension response was higher than with ablation of other atrial tissues.2 9 20 21 22 23 24 In the present study, we found no significant difference in HR and HRV between patients with bradycardia-hypotension response and those without this complication during ablation of PVs. The 2 subgroups showed transient autonomic dysfunction after ablation. This finding suggested that transient autonomic dysfunction occurred even in the absence of bradycardia-hypotension response (parasympathetic stimulation) during ablation of PVs.

Recovery of Autonomic Dysfunction After Ablation of PVs
Previous reports showed that autonomic dysfunction developed immediately after ablation of slow pathway or posteroseptal area and spontaneous resolution of HRV occurred 1 to 6 months later.1 2 3 4 5 6 Therefore, we performed 24-hour Holter monitoring at 1 and 6 months after ablation of PVs, respectively, to see the chronic changes in HRV. The results showed that an increase in HR and a decrease in HRV recovered at 1 month after ablation of PVs, indicating a transient dysfunction of autonomic nervous system, just as the findings after ablation of supraventricular tachycardias.

Clinical Implications
The present study provided some clinical implications in the patients who underwent ablation of PVs. First, the incidence of bradycardia-hypotension response induced by the transseptal puncture was low, and no evidence of autonomic dysfunction after the transseptal procedure was noted in the present study.30 However, focal PV ablation could induce a higher incidence of bradycardia-hypotension response and transient autonomic dysfunction. The transient alterations of autonomic function could explain the possible mechanism of palpitation (sinus tachycardia, without recurrence of paroxysmal AF) after ablation of PVs. Second, the change in autonomic function with enhanced sympathetic tone or parasympathetic withdrawal could cause atrial premature beats and spontaneous AF.

Study Limitations
The present study had several limitations. First, HRV is used to evaluate the variability of sinus node, and all of the beats not from the sinus node should be eliminated. Our patients had frequent attacks of paroxysmal AF, and the patients with abnormal beats that were >1% of the available beats were excluded. Thus, the patients with very frequent attacks of AF were not included. On the other hand, in patients with recurrence of AF after ablation of PVs who had abnormal beats that were >1% of sinus beats were also excluded. Otherwise, an increase in HR and a decrease in HRV might result from elevated sympathetic activity, decreased parasympathetic activity, or a combination of the 2 factors. Any factor that could affect autonomic tone also interfered with the HRV; these factors included postprocedural hypovolemia, pain, emotional stress, and some drugs (such as sedative or isoproterenol used during the procedure). To avoid the effects of these factors, we performed postablation 24-hour Holter monitoring 1 week after ablation. Finally, we could not rule out the possibility that the autonomic dysfunction was induced by transient edema of autonomic nerve fibers after PV ablation.

Conclusions
Focal ablation of PVs could result in an increase in HR and a decrease in time-domain and frequency-domain measures of HRV, which indicates autonomic dysfunction. These changes were transient and could resolve spontaneously 1 month later, which represents recovery of autonomic dysfunction.


*    Acknowledgments
 
This study was supported in part by grants from the National Science Council (NSC 88-2314-B-010-094, 88-2314-B-075-065, 88-2314-B-075-090, and 88-2314-B-010-093) and Tzou’s Medical Foundation (VGHYM87-S4-24 and VGHYM87-S3-17 and VGH-23, -36, -47, --61, --63, --64, --65, --254, and -301), Taipei, Taiwan, ROC.

Received March 10, 1999; revision received July 12, 1999; accepted July 20, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Friedman PL, Stevenson WG, Kocovic DZ. Autonomic dysfunction after catheter ablation. J Cardiovasc Electrophysiol. 1996;7:450–459.[Medline] [Order article via Infotrieve]

2. Kocovic DZ, Harada T, Shea JB, Soroff D, Friedman PL. Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia: delineation of parasympathetic pathways in the human heart. Circulation. 1993;88:1671–1681.[Abstract/Free Full Text]

3. Madrid AH, Mestre JL, Moro C, Vivas E, Tejero I, Novo L, Marin E, Orellana L. Heart rate variability and inappropriate sinus tachycardia after catheter ablation of supraventricular tachycardia. Eur Heart J. 1995;16:1637–1640.[Abstract/Free Full Text]

4. Pappone C, Stabile G, Oreto G, de Simone A, Rillo M, Mazzone P, Cappato R, Chierchia S. Inappropriate sinus tachycardia after radiofrequency ablation of para-hisian accessory pathways. J Cardiovasc Electrophysiol. 1997;8:1357–1365.[Medline] [Order article via Infotrieve]

5. Soejima K, Akaishi M, Mitamura H, Ogawa S, Sakurada H, Okazaki H, Motomiya T, Hiraoka M. Increase in heart rate after radiofrequency catheter ablation is mediated by parasympathetic nervous withdrawal and related to site of ablation. J Electrocardiol. 1997;30:239–246.[Medline] [Order article via Infotrieve]

6. Geller C, Goette A, Carlson MD, Esperer HD, Hartung WM, Auricchio A, Klein HU. An increase in sinus rate following radiofrequency energy application in the posteroseptal space. Pacing Clin Electrophysiol. 1998;21:303–307.[Medline] [Order article via Infotrieve]

7. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997;95:572–576.[Abstract/Free Full Text]

8. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Mouroux AL, Metayer PL, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666.[Abstract/Free Full Text]

9. Tsai CF, Chen SA, Tai CT, Chiou CW, Prakash VS, Yu WC, Hsieh MH, Ding YA, Chang MS. Bezold-Jarisch-like reflex during radiofrequency ablation of the pulmonary vein tissues in patients with paroxysmal focal atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:27–35.[Medline] [Order article via Infotrieve]

10. Hsieh MH, Chen SA, Tai CT, Tsai CF, Prakash VS, Yu WC, Liu CC, Ding YA, Chang MS. Double multielectrode mapping catheters facilitate radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. J Cardiovasc Electrophysiol. 1999;10:136–144.[Medline] [Order article via Infotrieve]

11. Wen ZC, Chen SA, Tai CT, Huang JL, Chang MS. Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter. J Am Coll Cardiol. 1998;31:602–607.[Abstract/Free Full Text]

12. Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA, Chang MS. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol. 1998;32:732–738.[Abstract/Free Full Text]

13. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220–222.[Abstract/Free Full Text]

14. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151–H153.[Abstract/Free Full Text]

15. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–1065.[Free Full Text]

16. Kay GN, Epstein AE, Dailey SM, Plumb VJ. Selective radiofrequency ablation of slow pathway for the treatment of atrioventricular nodal reentrant tachycardia: evidence for involvement of perinodal myocardium within the reentrant circuit. Circulation. 1992;85:1675–1688.[Abstract/Free Full Text]

17. Ehlert FA, Goldberger JJ, Brooks R, Miller S, Kadish AH. Persistent inappropriate sinus tachycardia after radiofrequency current catheter modification of the atrioventricular node. Am J Cardiol. 1992;62:1092–1095.

18. Skeberis V, Simonis F, Tsakonas K, Celiker A, Andries E, Brugada P. Inappropriate sinus tachycardia following radiofrequency catheter ablation of AV nodal tachycardia: Incidence and clinical significance. Pacing Clin Electrophysiol. 1994;17:924–927.[Medline] [Order article via Infotrieve]

19. Natale A, Klein G, Yee R. Shortening of fast pathway refractoriness after slow pathway ablation: effects of autonomic blockade. Circulation. 1994;89:1103–1108.[Abstract/Free Full Text]

20. Ardell JL, Randall WC. Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. Am J Physiol. 1986;20:H764–H773.

21. Lazzara R, Scherlag BJ, Robinson MJ, Samet P. Selective in situ parasympathetic control of the canine sinoatrial and atrioventricular nodes. Circ Res. 1973;32:393–401.[Abstract/Free Full Text]

22. Randall WC, Ardell JL. Nervous control of the heart: anatomy and pathophysiology. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology, From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:291–299.

23. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes: the third fat pad. Circulation. 1997;95:2573–2584.[Abstract/Free Full Text]

24. Marron K, Wharton J, Sheppard MN, Fagan D, Royston D, Kuhn DM, de Leval MR, Whitehead BF, Anderson RH, Polak JM. Distribution, mor-phology, and neurochemistry of endocardial and epicardial nerve terminal arborizations in the human heart. Circulation. 1995;92:2343–2351.[Abstract/Free Full Text]

25. Chiou CW, Zipes DP. Selective vagal denervation of the atria eliminates heart rate variability and baroreflex sensitivity while preserving ventricular innervation. Circulation. 1998;98:360–368.[Abstract/Free Full Text]

26. Schwartz PJ, Pagani M, Lombardi F, Malliani A, Brown AM. A cardiac sympathovagal reflex in the cat. Circ Res. 1973;32:215–220.[Abstract/Free Full Text]

27. Kostreva DR, Zuperku EJ, Purtock RV, Coon RL, Kampine JP. Sympathetic afferent nerve activity. Am J Physiol. 1975;229:911–915.

28. Malliani A, Peterson DF, Bishop VS, Brown AM. Spinal sympathetic cardiovascular reflexes. Circ Res. 1972;30:158–166.[Abstract/Free Full Text]

29. Chen SA, Chiang CE, Tai CT, Wen ZC, Lee SH, Chiou CW, Ding YA, Chang MS. Intracardiac stimulation of human parasympathetic nerve fibers induce negative dromotropic effects: implication with the lesions of radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 1998;9:245–252.[Medline] [Order article via Infotrieve]

30. Croft CH, Lipscomb K. Modified technique of transseptal left heart catheterization. J Am Coll Cardiol. 1985;5:904–910.[Abstract]




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham
Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Miyanaga, T. Yamane, T. Date, M. Tokuda, Y. Aramaki, K. Inada, K. Shibayama, S. Matsuo, H. Miyazaki, K. Abe, et al.
Impact of pulmonary vein isolation on the autonomic modulation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses
Europace, May 1, 2009; 11(5): 576 - 581.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Ketels, R. Houben, K. Van Beeumen, R. Tavernier, and M. Duytschaever
Incidence, timing, and characteristics of acute changes in heart rate during ongoing circumferential pulmonary vein isolation
Europace, December 1, 2008; 10(12): 1406 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
E. Pokushalov, A. Turov, P. Shugayev, S. Artyomenko, A. Romanov, and N. Shirokova
Catheter Ablation of Left Atrial Ganglionated Plexi for Atrial Fibrillation
Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 194 - 201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Arora, J. S. Ulphani, R. Villuendas, J. Ng, L. Harvey, S. Thordson, F. Inderyas, Y. Lu, D. Gordon, P. Denes, et al.
Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H134 - H144.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace, June 1, 2007; 9(6): 335 - 379.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-Y. Kuo and S.-A. Chen
Is Vagal Denervation a Good Alternative or Just Adjunctive to Pulmonary Vein Isolation in Catheter Ablation of Atrial Fibrillation?
J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1349 - 1351.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
CirculationHome page
M. Scanavacca, C. F. Pisani, D. Hachul, S. Lara, C. Hardy, F. Darrieux, I. Trombetta, C. E. Negrao, and E. Sosa
Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation
Circulation, August 29, 2006; 114(9): 876 - 885.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Y. Tan, H. Li, S. Wachsmann-Hogiu, L. S. Chen, P.-S. Chen, and M. C. Fishbein
Autonomic Innervation and Segmental Muscular Disconnections at the Human Pulmonary Vein-Atrial Junction: Implications for Catheter Ablation of Atrial-Pulmonary Vein Junction
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm
Current strategies in the management of atrial fibrillation.
Ann. Thorac. Surg., July 1, 2006; 82(1): 357 - 364.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
B. Nilsson, X. Chen, S. Pehrson, Jør. Hilden, and J. H. Svendsen
Increased resting heart rate following radiofrequency catheter ablation for atrial fibrillation
Europace, January 1, 2005; 7(5): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Grossman, F. H. Wilhelm, and M. Spoerle
Respiratory sinus arrhythmia, cardiac vagal control, and daily activity
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H728 - H734.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Pappone, G. Oreto, S. Rosanio, G. Vicedomini, M. Tocchi, F. Gugliotta, A. Salvati, C. Dicandia, M. P. Calabro, P. Mazzone, et al.
Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation
Circulation, November 20, 2001; 104(21): 2539 - 2544.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S.A. Chen, C.T. Tai, M.H. Hsieh, C.F. Tsai, Y.A. Ding, and M.S. Chang
Radiofrequency catheter ablation of atrial fibrillation initiated by spontaneous ectopic beats
Europace, January 1, 2000; 2(2): 99 - 105.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, M.-H.
Right arrow Articles by Chen, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, M.-H.
Right arrow Articles by Chen, S.-A.
Related Collections
Right arrow Pulmonary circulation and disease
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Arrhythmias, clinical electrophysiology, drugs